Pictet Asset Management (Switzerland)’s Theravance Biopharma TBPH Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio TBPH Stock Details TBPH Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$19.1M	Buy
2023 Q1	$15.8M	Buy
2022 Q4	$5.53M	Buy
2022 Q3	$3.76M	Buy
2022 Q2	$2.37M	Buy
2022 Q1	$1.79M	Sell
2021 Q4	$2.25M	Hold
2021 Q3	$1.51M	Buy